Citation Impact
Citing Papers
Zygomycetes in Human Disease
2000 Standout
Clinical Practice Guidelines for the Diagnosis and Management of Intravascular Catheter-Related Infection: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Presence of Candida cell wall derived polysaccharides in the sera of intensive care unit patients: relation with candidaemia and Candida colonisation
2014
Clinical Practice Guidelines for the Management Candidiasis: 2009 Update by the Infectious Diseases Society of America
2009 Standout
Platelet activation and platelet-monocyte aggregate formation trigger tissue factor expression in patients with severe COVID-19
2020 Standout
Epidemiology of Invasive Candidiasis: a Persistent Public Health Problem
2007 Standout
Tryptophan Catabolites from Microbiota Engage Aryl Hydrocarbon Receptor and Balance Mucosal Reactivity via Interleukin-22
2013 Standout
No health without mental health
2007 Standout
Total Nutrient Admixtures Appear Safer than Lipid Emulsion Alone as Regards Microbial Contamination: Growth Properties of Microbial Pathogens at Room Temperature
1998
Combination and Sequential Antifungal Therapy for Invasive Aspergillosis: Review of Published In Vitro and In Vivo Interactions and 6281 Clinical Cases from 1966 to 2001
2003
Nosocomial Cluster of Candida guillermondii Fungemia in Surgical Patients
2003
Plasma Levels of Soluble CD14 Independently Predict Mortality in HIV Infection
2011
Invasive Mycoses: Diagnostic Challenges
2011
Vulvovaginal candidosis
2007 Standout
An Acquired and Endogenous Glycocalyx Forms a Bidirectional “Don’t Eat” and “Don’t Eat Me” Barrier to Phagocytosis
2020 StandoutNobel
Therapeutic potential of resveratrol: the in vivo evidence
2006 Standout
Environmental and health effects of the herbicide glyphosate
2017 Standout
Nosocomial Candidiasis: Emerging Species, Reservoirs, and Modes of Transmission
1996
Interactions between the microbiota, immune and nervous systems in health and disease
2017 Standout
Posaconazole or Fluconazole for Prophylaxis in Severe Graft-versus-Host Disease
2007 Standout
A Prospective Clinical Trial of a Real-Time Polymerase Chain Reaction Assay for the Diagnosis of Candidemia in Nonneutropenic, Critically Ill Adults
2008
The Changing Clinical Spectrum of Human Immunodeficiency Virus (HIV)-Related Oral Lesions in 1,000 Consecutive Patients
2003
Investigation of the possible association between nosocomial candiduria and candidaemia
2006
Sphingolipids and their metabolism in physiology and disease
2017 Standout
Early Immunologic Failure is Associated With Early Mortality Among Advanced HIV–Infected Adults Initiating Antiretroviral Therapy With Active Tuberculosis
2013 StandoutNobel
Changing role of invasive aspergillosis in AIDS — a case control study
1998
Use of DNA Moderately Repetitive Sequence to Type Aspergillus fumigatus Isolates from Aspergilloma Patients
1994
Effect of Solar Particle Event Radiation and Hindlimb Suspension on Gastrointestinal Tract Bacterial Translocation and Immune Activation
2012 StandoutNobel
Fungal infections in cancer patients: An international autopsy survey
1992
Genetic Variation of Innate Immune Genes in HIV-Infected African Patients With or Without Oropharyngeal Candidiasis
2010
Detection of β-glucans using an amperometric biosensor based on high-affinity interaction between Dectin-1 and β-glucans
2010
Antibodies, killer toxins and antifungal immunoprotection: a lesson from nature?
1997
Damaged Intestinal Epithelial Integrity Linked to Microbial Translocation in Pathogenic Simian Immunodeficiency Virus Infections
2010
Opportunistic Candidiasis: An Epidemic of the 1980s
1995
Microbial translocation, immune activation, and HIV disease
2012
Therapeutic Outcome in Invasive Aspergillosis
1996
Increased Platelet and Microparticle Activation in HIV Infection
2011
Guideline for Prevention of Intravascular-Device–Related Infections
1996
Role of the Microbiota in Immunity and Inflammation
2014 Standout
The Risk of Bloodstream Infection in Adults With Different Intravascular Devices: A Systematic Review of 200 Published Prospective Studies
2006
Guideline for Prevention of Intravascular-Device-Related Infections
1996
Endotoxemia Is Associated with Altered Innate and Adaptive Immune Responses in Untreated HIV-1 Infected Individuals
2011
Epidemiology and Outcome of Zygomycosis: A Review of 929 Reported Cases
2005 Standout
Intensification of Antiretroviral Therapy With Raltegravir or Addition of Hyperimmune Bovine Colostrum in HIV-Infected Patients With Suboptimal CD4+ T-Cell Response: A Randomized Controlled Trial
2011
An EORTC multicentre prospective survey of invasive aspergillosis in haematological patients: Diagnosis and therapeutic outcome
1998
A Randomized, Double-Blind, Parallel-Group, Dose-Response Study of Micafungin Compared with Fluconazole for the Treatment of Esophageal Candidiasis in HIV-Positive Patients
2004
Restriction Endonuclease Analysis of Total Cellular DNA of Aspergillus fumigatus Isolates of Geographically and Epidemiologically Diverse Origin
1990
A Randomized, Double‐Blind, Double‐Dummy, Multicenter Trial of Voriconazole and Fluconazole in the Treatment of Esophageal Candidiasis in Immunocompromised Patients
2001
Has the Epidemiology of Nosocomial Candidemia Changed?
2004
Echinocandin antifungal drugs
2003 Standout
Infections due to emerging and uncommon medically important fungal pathogens
2004
The end of AIDS: HIV infection as a chronic disease
2013 Standout
Echinocandin resistance
2014
A Review of Risk Factors for Catheter-Related Bloodstream Infection Caused by Percutaneously Inserted, Noncuffed Central Venous Catheters
2002
Chronic disseminated candidiasis in patients with acute leukemia: emphasis on diagnostic definition and treatment
2004
Aspergillosis Case-Fatality Rate: Systematic Review of the Literature
2001 Standout
Trends in Mortality Due to Invasive Mycotic Diseases in the United States, 1980–1997
2001
Plant Polyphenols: Chemical Properties, Biological Activities, and Synthesis
2011 Standout
Epidemiology of oral candidiasis in HIV-infected patients: Colonization, infection, treatment, and emergence of fluconazole resistance
1994
Current Treatment Strategies for Disseminated Candidiasis
2005
Mitochondrial Membrane Permeabilization in Cell Death
2007 Standout
In vitro activity of a new echinocandin, LY303366, and comparison with fluconazole, flucytosine and amphotericin B against Candida species† †This study was presented, in part, at the 37th ICAAC in Toronto, Canada, 28th September – 1st October 1997.
2001
Impact of CD8+ T-cell activation on CD4+ T-cell recovery and mortality in HIV-infected Ugandans initiating antiretroviral therapy
2011
Therapeutic potential of antiidiotypic single chain antibodies with yeast killer toxin activity
1997
Invasive Infection Due to Candida krusei in Immunocompromised Patients Not Treated with Fluconazole
1995
Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy
2000
HIV-Related Neuropathology, 1985 to 1999: Rising Prevalence of HIV Encephalopathy in the Era of Highly Active Antiretroviral Therapy
2002
Revisiting the Source of Candidemia: Skin or Gut?
2001
Pulmonary Aspergillosis and Invasive Disease in AIDS
1998
Problems and Controversies in the Management of Hematogenous Candidiasis
1996
Regulation of type I interferon responses
2013 Standout
Periodontal diseases
2005 Standout
Disturbance of the gut-associated lymphoid tissue is associated with disease progression in chronic HIV infection
2009
Microbial chemical signaling: a current perspective
2012
Antifungal susceptibilities of Candida spp. isolated from blood in Spain and Argentina, 1996-1999
2002
Fungal vaccines: real progress from real challenges
2008
Epidemiology of Candidaemia in Europe: Results of 28-Month European Confederation of Medical Mycology (ECMM) Hospital-Based Surveillance Study
2004
Defining trained immunity and its role in health and disease
2020 Standout
Immunity to fungal infections
2011 Standout
Guidelines for the Prevention of Intravascular Catheter-related Infections
2011 Standout
THE PROTECTIVE IMMUNE RESPONSE AGAINST VAGINAL CANDIDIASIS: LESSONS LEARNED FROM CLINICAL STUDIES AND ANIMAL MODELS
2002
Contribution of Serological Tests and Blood Culture to the Early Diagnosis of Systemic Candidiasis
2001
Complications of Femoral and Subclavian Venous Catheterization in Critically Ill Patients<SUBTITLE>A Randomized Controlled Trial</SUBTITLE>
2001 Standout
European Confederation of Medical Mycology (ECMM) prospective survey of candidaemia: report from one Italian region
2002
Therapy of mucosal candidiasis by expression of an anti-idiotype in human commensal bacteria
2000
Prebiotics Reduce Body Fat and Alter Intestinal Microbiota in Children Who Are Overweight or With Obesity
2017
-D-Glucan as a Diagnostic Adjunct for Invasive Fungal Infections: Validation, Cutoff Development, and Performance in Patients with Acute Myelogenous Leukemia and Myelodysplastic Syndrome
2004
Guideline for Prevention of Intravascular-Device–Related Infections
1996
Circulating microRNAs in Sera Correlate with Soluble Biomarkers of Immune Activation but Do Not Predict Mortality in ART Treated Individuals with HIV-1 Infection: A Case Control Study
2015 Standout
HEPATOSPLENIC CANDIDIASIS
2000
Efficacy and Safety of Fluconazole Prophylaxis for Fungal Infections after Marrow Transplantation--A Prospective, Randomized, Double-Blind Study
1995
Interactions of fungal pathogens with phagocytes
2016
Early diagnosis of invasive candidiasis with mannan antigenemia and antimannan antibodies
2004
Randomized, Comparative, Double-Blind, Double-Dummy, Multicenter Trial of Miconazole Buccal Tablet and Clotrimazole Troches for the Treatment of Oropharyngeal Candidiasis: Study of Miconazole Lauriad®Efficacy and Safety (SMiLES)
2010
PD-1 coinhibitory signals: The link between pathogenesis and protection
2013
Gut microbiota in human metabolic health and disease
2020 Standout
Posaconazole vs. Fluconazole or Itraconazole Prophylaxis in Patients with Neutropenia
2007 Standout
Atroposelective Total Synthesis of Axially Chiral Biaryl Natural Products
2010 Standout
Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management
2015 Standout
Integrating gut microbiota immaturity and disease‐discriminatory taxa to diagnose the initiation and severity of shrimp disease
2017 Standout
Development of DNA probes for fingerprinting Aspergillus fumigatus
1993
Gut Microbiota in Health and Disease
2010 Standout
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases
2019 Standout
PCR Diagnosis of Invasive Candidiasis: Systematic Review and Meta-Analysis
2010
Binding of extracellular matrix proteins to Aspergillus fumigatus conidia
1996
Protective role of antimannan and anti-aspartyl proteinase antibodies in an experimental model of Candida albicans vaginitis in rats
1997
The Epidemiological Features of Invasive Mycotic Infections in the San Francisco Bay Area, 1992-1993: Results of Population-Based Laboratory Active Surveillance
1998
Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies.
2004 Standout
Fusarium, a Significant Emerging Pathogen in Patients With Hematologic Malignancy: Ten Years' Experience at a Cancer Center and Implications for Management
1997
Zygomycetes in Human Disease
2000 Standout
Antifungal Susceptibility ofCandidaBiofilms: Unique Efficacy of Amphotericin B Lipid Formulations and Echinocandins
2002
Laboratory diagnosis of invasive candidiasis.
2005
Preventing Complications of Central Venous Catheterization
2003 Standout
Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of America
2011 Standout
Commensal Host-Bacterial Relationships in the Gut
2001 StandoutScience
Specific binding of human fibrinogen fragment D to Aspergillus fumigatus conidia
1992
The medically important aerobic actinomycetes: epidemiology and microbiology
1994 Standout
Incomplete Immune Recovery in HIV Infection: Mechanisms, Relevance for Clinical Care, and Possible Solutions
2012
Application of polymerase chain reaction to fingerprinting Aspergillus fumigatus by random amplification of polymorphic DNA
1993
Engineering microbial consortia: a new frontier in synthetic biology
2008 StandoutNobel
Typing by immunoblot of Aspergillus fumigatus from nosocomial infections.
1994
Extended-Spectrum β-Lactamases: a Clinical Update
2005 Standout
Invasive Candidiasis
2015 Standout
New and emerging yeast pathogens
1995
Proprietes antibacteriennes et genotoxiques de 33 mycotoxines
1984
Clinical Practice Guideline for the Management of Candidiasis: 2016 Update by the Infectious Diseases Society of America
2015 Standout
The Commonality of Risk Factors for Nosocomial Colonization and Infection with Antimicrobial-Resistant Staphylococcus aureus, Enterococcus, Gram-Negative Bacilli, Clostridium difficile, and Candida
2002
Gold Nanoparticles in Chemical and Biological Sensing
2012 Standout
Numerical index of the discriminatory ability of typing systems: an application of Simpson's index of diversity
1988 Standout
Rare and Emerging Opportunistic Fungal Pathogens: Concern for Resistance beyondCandida albicansandAspergillus fumigatus
2004
The short-chain fatty acid propionate increases glucagon and FABP4 production, impairing insulin action in mice and humans
2019
Molecular epidemiology of nosocomial invasive aspergillosis
1994
The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition
2014 Standout
Comparison of three typing methods for clinical and environmental isolates of Aspergillus fumigatus
1995
Sphingolipids as Targets for Treatment of Fungal Infections
2016
Aspergillus fumigatusand Aspergillosis
1999 Standout
Therapeutic Activity of an Engineered Synthetic Killer Antiidiotypic Antibody Fragment against Experimental Mucosal and Systemic Candidiasis
2003
Antibody immunity and invasive fungal infections
1995
Interplay between Protective and Inhibitory Antibodies Dictates the Outcome of Experimentally Disseminated Candidiasis in Recipients of aCandida albicansVaccine
2002
Antifungal Susceptibility Testing: Practical Aspects and Current Challenges
2001
Preparation and purification of monoclonal antibodies for Aspergillus fumigatus.
1991
Microbial Translocation Across the GI Tract
2012
Increased tissue factor expression on circulating monocytes in chronic HIV infection: relationship to in vivo coagulation and immune activation
2009
Comparison of Biofilms Formed byCandidaalbicansandCandidaparapsilosison Bioprosthetic Surfaces
2002
Typing by irnrnunoblot ofAspergillus fumigatusfrom nosocornial infections
1993
Combined detection of mannanaemia and anti-mannan antibodies as a strategy for the diagnosis of systemic infection caused by pathogenic Candida species
2002
Works of Giulia Morace being referenced
App1: An Antiphagocytic Protein That Binds to Complement Receptors 3 and 2
2009
Pediatric obesity is associated with an altered gut microbiota and discordant shifts in F irmicutes populations
2016
Epidemiological and clinical aspects of mycoses in patients with aids-related pathologies
1990
In vitro Susceptibility of 119 Yeast Isolates to Fluconazole, 5-Fluorocytosine, Amphotericin B and Ketoconazole
1991
Interfaces of the Yeast Killer Phenomenon
1991
Blastoschizomyces capitatus: An Emerging Cause of Invasive Fungal Disease in Leukemia Patients
1990
An emerging opportunistic infection in HIV patients: A retrospective analysis of 11 cases of pulmonary aspergillosis
1993
Candidemia in HIV-Infected Subjects
1999
Morbidity associated with central venous catheter-use in a cohort of 212 hospitalized subjects with HIV infection
2000
Idiotypic Vaccination: Immunoprotection Mediated by Anti‐idiotypic Antibodies with Antibiotic Activity
1993
Commercial systems for fluconazole susceptibility testing of yeasts: comparison with the broth microdilution method
2000
Microbial translocation is associated with sustained failure in CD4+ T-cell reconstitution in HIV-infected patients on long-term highly active antiretroviral therapy
2008
New strategic insights into managing fungal biofilms
2015
Adjuvant therapy with rhGM-CSF for the treatment of Blastoschizomyces capitatus systemic infection in a patient with acute myeloid leukemia
1996
Retrospective study of candidemia in patients with hematological malignancies. Clinical features, risk factors and outcome of 76 episodes
1999
Invasive Fusarium solani Infections in Patients with Acute Leukemia
1988
Microbiota in anorexia nervosa: The triangle between bacterial species, metabolites and psychological tests
2017
Comparative analysis of prognostic indicators of aspergillosis in haematological malignancies and HIV infection
1997
Biotyping of aerobic actinomycetes by modified killer system
1988
Nosocomial Outbreak of Systemic Candidosis Associated With Parenteral Nutrition
1990
An anthraquinone and three naphthopyrone derivatives from Cassia pudibunda
1991
Antifungal activity of Myriocin on clinically relevant Aspergillus fumigatus strains producing biofilm
2015
In vitro activity of voriconazole and other antifungal agents against clinical isolates of Candida glabrata and Candida krusei
2004
Role of Protease Inhibitors in Preventing Recurrent Oral Candidosis in Patients With HIV Infection: A Prospective Case-Control Study
1999
‘Antibiobodies’: antibiotic-like anti-idiotypic antibodies
1991
In- VitroComparative Activity of Fluconazole and Other Antifungal Agents AgainstBlastoschizomyces capitatus
1991
Hansenula anomala killer toxin induces secretion and severe acute injury in the rat intestine
1995
The Role of the Laboratory in the Diagnosis of Invasive Candidiasis
2009
Antigenic studies on Rhizopus microsporus, Rh. rhizopodiformis, progeny and intermediates (Rh. chinensis)
1988
The Role of Bronchoalveolar Lavage in the Microbiological Diagnosis of Pneumonia in Patients with Haematological Malignancies
1997
Detection by immunofluorescent anti-idiotypic antibodies of yeast killer toxin cell wall receptors of Candida albicans
1990
Surface Localization of Glucosylceramide during Cryptococcus neoformans Infection Allows Targeting as a Potential Antifungal
2011
Fluconazole-Resistant Candida parapsilosis Fungemia in a Patient with AIDS
1996
Studies on the epidemiology of Aspergillus fumigatus infections in a university hospital
1989
Identification of various medically important Candida species in clinical specimens by PCR-restriction enzyme analysis
1997
Identification and serotyping of Microsporum canis isolates by monoclonal antibodies
1986
Reevaluation of the yeast killer phenomenon
1986
Antifungal resistance does not necessarily affectCandida glabratafitness
2013
Yeast killer toxin-like anti-idiotypic antibodies
1988
Idiotypic intravaginal vaccination to protect against candidal vaginitis by secretory, yeast killer toxin-like anti-idiotypic antibodies.
1994
Rhinocerebral zygomycosis in acute lymphoblastic leukaernia
1993
Preliminary studies on the carcinogenic effects of Penicillium roqueforti toxin (PR toxin) on rats
1982
Pulmonary aspergillosis in patients with hematologic malignancies: clinicoradiologic correlation.
1995
Production and characterization of yeast killer toxin monoclonal antibodies
1987
Nosocomial Outbreak of Systemic Candidosis Associated With Parenteral Nutrition
1990
Reverse Cross Blot Hybridization Assay for Rapid Detection of PCR-Amplified DNA from Candida Species, Cryptococcus neoformans , and Saccharomyces cerevisiae in Clinical Samples
2000
Fungal infections in ICU patients: epidemiology and the role of diagnostics.
2010
PCR-Restriction Enzyme Analysis for Detection of Candida DNA in Blood from Febrile Patients with Hematological Malignancies
1999
Evaluation of the utility of serological tests in the diagnosis of candidemia.
1999
Killer system: a simple method for differentiating Candida albicans strains
1983
Invasive Mold Infections: Virulence and Pathogenesis ofMucorales
2011
Biosynthesis and Immunogenicity of Glucosylceramide inCryptococcus neoformansand Other Human Pathogens
2007